REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.475
Bid: 1.45
Ask: 1.50
Change: -0.075 (-4.84%)
Spread: 0.05 (3.448%)
Open: 1.55
High: 1.55
Low: 1.475
Prev. Close: 1.55
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Aston Martin CEO ups stake; Alkemy's lithium deal

Tue, 03rd Oct 2023 17:14

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Aston Martin Lagonda Global Holdings PLC - Gaydon, England-based luxury sports car manufacturer - Chief Executive Lawrence Stroll increases stake to 26% from 23% on October 3.

----------

Edinburgh Investment Trust PLC - Edinburgh-based investment trust - Liontrust Fund Partners LLP informs company that James de Uphaugh, the company's portfolio manager, will retire in February 2024. De Uphaugh will continue to manage the portfolio until February and will then be replaced as by Imran Sattar. As part of the succession, Sattar has been appointed deputy portfolio manager, replacing Chris Field who is due to retire from Liontrust in November. Other than the change of portfolio manager, there will be no change to the two investment objectives, strategy or the portfolio's key features, company says.

----------

DWF Group PLC - Manchester, England-based legal business with operations in North America - Announces the scheme which facilitates the bid by Inflexion Private Equity Partners LLP has become effective. The entire issued share capital of DWF is now owned or controlled by Inflexion. Shares in DWF have been suspended and are expected to be cancelled on October 4. As a result of the scheme becoming effective, DWF announces that: Teresa Colaianni, Samantha Duncan, Luke Savage, Jonathan Bloomer and Chris Sullivan have resigned as non-executive directors with effect from October 3. Further, Seema Bains and Michele Cicchetti have resigned as partner directors of the board with effect from October 3.

----------

Angus Energy PLC - UK-focused oil and gas development company - Reports gas volumes produced and sold from the Saltfleetby Field equalled 7.9 million therms in aggregate for the months of July, August and September, compared to 6.8 million therms produced and sold in the second quarter of this year. Notes third quarter production equates to an average of 2.6 million therms per month, up from 2.3 million therms per month in the second quarter, and against hedged volumes of 1.5 million therms per month for the third quarter, down from 1.75 million therms per month for the second quarter. Operational efficiency was 90% for the third quarter compared to 88% operational efficiency for the second quarter. The quarter included a planned full plant shut down for four days at the end of August for safety-critical maintenance and remedial work on one of the two compressor engines on the Saltfleetby site. Further, states work on the previously announced global refinance of the company's debt is well advanced, with a new reservoir model and production forecasts in the process of being finalized for lenders.

----------

Alkemy Capital Investments PLC - London-based company focused on acquisitions in the mining and technology metals sectors - Says Tees Valley Lithium has been shortlisted by a major automotive original equipment manufacturer as the preferred European lithium refiner for a portion of its lithium supply chain after extensive due diligence. Explains Tees Valley is a wholly owned UK subsidiary. Explains the due diligence focussed on Tees Valley Lithium's ability to import a lithium sulphate from its Port Hedland facility in Western Australia and the conversion into battery grade lithium hydroxide or carbonate at an internationally competitive price. Discussions are also advancing well with third parties, including other automotive OEMs, for access to Tees Valley Lithium's multi-train facilities, company states. Further, discussions are ongoing with two major trading groups to supply technical grade carbonate from South America and elsewhere to feed directly one of the trains at Tees Valley Lithium's Wilton refinery to produce battery grade lithium products on a toll treatment basis.

----------

City of London Investment Group PLC - investor in London-listed equities - Confirms Barry Aling will be retiring as non-executive chair at the annual general meeting on October 23. Says Rian Dartnell, a current non-executive director will become chair. Further, says Ted Sevick has been promoted to chief operating officer.

----------

Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy for iron deficiency - Confirms retail offer, launched on September 28, raised GBP118,337 taking total of fundraise to GBP5.1 million. The retail offer will result in the issue of a total of around 1.5 million shares.

----------

More News
19 Sep 2018 08:36

Shield Therapeutics irons losses, agrees commercialisation deal

(Sharecast News) - Iron deficiency treatment specialist Shield Therapeutics narrowed losses as revenues grew in the first half of that saw a series of positive developments.

Read more
13 Sep 2018 11:51

Shield Therapeutics Completes Recruitment For Feraccru Trial

LONDON (Alliance News) - Shield Therapeutics PLC said on Thursday it has completed recruitment of patients for the AEGIS-H2H Phase 3b study of oral Feraccru in subjects suffering from inflammatory

Read more
26 Jul 2018 13:05

Shield Therapeutics Appoints Hans-Peter Hasler To Board

LONDON (Alliance News) - Shield Therapeutics PLC, a commercial stage pharmaceutical company, said Thursday that it has appointed Hans-Peter Hasler as non-executive director with immediate is the a

Read more
20 Jun 2018 16:09

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 21 JuneHSS Hire GroupFriday 22 JuneCambian Fifteen Communications Shipping 25

Read more
14 Jun 2018 13:48

Shield Therapeutics Reports Positive Results From Feraccru Study

LONDON (Alliance News) - Pharmaceutical company Shield Therapeutics PLC said Thursday it has had positive top-line results from its paediatric phase I pharmacokinetics study of its ferric iron is

Read more
12 Jan 2017 09:04

Diurnal Hires Outgoing Mereo BioPharma Finance Chief Bungay

Read more
6 Jan 2017 08:12

Shield Therapeutics sees 'encouraging' demand for oral iron product in England, Germany

(ShareCast News) - AIM-listed pharmaceutical Shield Therapeutics saw "encouraging" demand for its oral iron product in the England and Germany. The company said is seeing "very encouraging signals of demand" after only six months since the commercial launch of Feraccru, which treats of iron deficien

Read more
14 Jun 2016 09:17

Shield Therapeutics Reports Widened Pretax Loss In Maiden 2015 Results

Read more
7 Jun 2016 15:06

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
26 Feb 2016 09:17

Shield Therapeutics Starts Trading, Gets European Feraccru Approval (ALLIPO)

Read more
12 Feb 2016 11:50

Shield Therapeutics Raises GBP32.5 Million In Delayed AIM IPO (ALLIPO)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.